ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

“I’m Not Bummed Out By This” – Broder

December 22, 1994

Hatfield, Kennedy Bill would Establish Panel for Clinical Research

February 16, 1996

IOM Says “Immediate Steps” Needed To Avert “Crisis” In Cancer Centers Program Funding

April 28, 1989

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001